General MedicationsORALGeneric
SOAANZ
TORSEMIDE
Standard Dose
60MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Discontinued
Summary
Approval overview SOAANZ is listed in Drugs@FDA under application 213218 (NDA).
Review priority: N/A Marketing status: Discontinued Active ingredient TORSEMIDE Form and strength TABLET;ORAL - 60MG Sponsor SARFE PHARMS Submission history Latest submission status date: 2021-11-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview SOAANZ is listed in Drugs@FDA under application 213218 (NDA). Review priority: N/A Marketing status: Discontinued Active ingredient TORSEMIDE Form and strength TABLET;ORAL - 60MG Sponsor SARFE PHARMS Submission history Latest submission status date: 2021-11-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.